Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
Cajetan Reichardt, Clinical Research Assistant at TUM University Hospital – German Heart Center, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Revista Española de Cardiología, adding:
“Thrilled to share my first scientific publication as a joint first author!
Our systematic review and meta-analysis, ‘Percutaneous Left Atrial Appendage Occlusion vs. Oral Anticoagulation in Patients with Atrial Fibrillation‘ has been recently published in Revista Española de Cardiología (IF 4.2)
7 studies, 7,353 participants
Study highlight: We reviewed randomized clinical trials comparing percutaneous LAAO with OACs (either a vitamin K antagonist or a direct oral anticoagulant) in patients with AF.
Key results: There were no significant differences between LAAO and OAC in terms of all-cause death, stroke or any bleeding.
LAAO reduced nonprocedural bleeding, but was associated with a numerically higher risk of ischemic stroke. There was a significant interaction between LAAO and the type of OAC regimen in terms of all-cause death.
I would like to express my sincere gratitude to my co-authors Maddalena Immobile Molaro and Fiorenzo Simonetti, mentors and colleagues for their hard work and collaboration!”
Title: Percutaneous left atrial appendage occlusion versus oral anticoagulation in patients with atrial fibrillation: a systematic review and meta-analysis
Authors: Maddalena Immobile Molaro, Cajetan Reichardt, Fiorenzo Simonetti, Doruntina Lahu, Gjin Ndrepepa, Tobias Lenz, Costanza Pellegrini, Moritz von Scheidt, Tobias Rheude, Felix Voll, Héctor Alfonso Álvarez Covarrubias, Teresa Trenkwalder, Hendrik B. Sager, Heribert Schunkert, Michael Joner, Adnan Kastrati, Salvatore Cassese, Erion Xhepa

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support
-
Nov 17, 2026, 23:34Ahmed Bennis: Is Aspirin Therapy Enough for VTE Prevention After Arthroplasty?
-
Nov 17, 2026, 23:33Remi Remakanth: The Role of Transfusion Medicine in HLA Antibody Testing and Transplant Desensitization
-
Nov 17, 2026, 15:26Hereditary Hemorrhagic Telangiectasia: The Molecular Connection Between Vascular Malformations and Bleeding